Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Went on Plaxivid same day I tested positive/4 days later tested positive with symptoms; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Went on Plaxivid same day I tested positive/4 days later tested positive with symptoms) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Unspecified drug.) and Asthma (Minor). Concomitant products included AMLODIPINE BESILATE, VALSARTAN (AMLODIPINE/VALSARTAN) for an unknown indication.    On 14-Dec-2021 at 7:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2022, the patient experienced COVID-19 (Went on Plaxivid same day I tested positive/4 days later tested positive with symptoms). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 10-May-2022 to 15-May-2022 for COVID-19 treatment, at an unspecified dose and frequency; AMOXICILLIN SODIUM, CLAVULANATE POTASSIUM (AMOXICILLIN/CLAVULANIC ACID [AMOXICILLIN SODIUM;CLAVULANATE POTASSIUM]) at an unspecified dose and frequency and METHYLPREDNISOLONE at an unspecified dose and frequency. In May 2022, COVID-19 (Went on Plaxivid same day I tested positive/4 days later tested positive with symptoms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-May-2022, SARS-CoV-2 test: positive Positive. In May 2022, SARS-CoV-2 test: negative Tested negative for 3 days. On 23-May-2022, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment.  The patient went on Paxlovid same day the patient tested positive. After 5 days of COVID, patient tested negative for 3 days, 4 days later patient tested positive with symptoms.  Company comment: This case concerns a patient of unknown age and gender with no relevant medical history reported, who experienced the adverse event of special interest of COVID-19 an unknown time after a dose of mRNA-1273. The patient received treatment with NIRMATRELVIR, RITONAVIR , after which they tested negative and then positive again for COVID-19. Other treatment provided included amoxicillin-clavulanic acid and methylprednisolone. Outcome was reported as resolving. The benefit-risk relationship of mRNA-1273 is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This case concerns a patient of unknown age and gender with no relevant medical history reported, who experienced the adverse event of special interest of COVID-19 an unknown time after a dose of mRNA-1273. The patient received treatment with NIRMATRELVIR, RITONAVIR , after which they tested negative and then positive again for COVID-19. Other treatment provided included amoxicillin-clavulanic acid and methylprednisolone. Outcome was reported as resolving. The benefit-risk relationship of mRNA-1273 is not affected by this report.